
“After progress in a second round of tests using stem cells to regrow nerve fibres, the China Spinal Cord Injury Network (ChinaSCINet) has applied for regulatory approval in China for a third and final phase, which it hopes to start in the autumn. 15 out of 20 patients in the Chinese city of Kunming, who received umbilical cord blood cell transplants and intensive walking therapy, were on average able to walk with minimal assistance seven years after complete spinal cord injury. The treatment involves injecting umbilical cord blood mononuclear cells into patients’ damaged spines to help regenerate nerves, while lithium is used to promote the growth of the nerve fibres.”
Related posts:
FDA sets Obamacare menu rules for food chains, other eateries
Stone Lion Capital Partners Suspends Redemptions in Credit Hedge Funds
The perils of overseas tax disclosure: An immigrant's story
Greece passes more spending cuts, tax hikes after third EU bailout
Supreme Court rules in favor of Florida property owner over denied development permit
Spain bans e-cigarettes in public spaces
Siskel & Ebert Review of Enemy of the State (1998)
Vitamins That Cost Pennies a Day Seen Delaying Dementia
TV's Unnatural Monopolies
U.S. Air Force can’t find enough people willing to be drone pilots
Austria, Luxembourg to give up banking secrecy for foreigners
Saudi princess snaps up luxurious Geneva estate for $62 million
Fatal shooting of double amputee sparks call for Houston police reforms
Cayman FATCA Agreement Makes It Tougher for Wealthy Americans to Hide Money
Canadian banks to be compelled to share clients' info with U.S.